INSITE VISION INC
SC 13D/A, 2000-01-11
PHARMACEUTICAL PREPARATIONS
Previous: EPITOPE INC/OR/, DEF 14A, 2000-01-11
Next: MUTUAL FUND INVESTMENT TRUST, 40-17F2, 2000-01-11






<PAGE>

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934

Amendment No.:  2

Name of Issuer:  Insite Vision Incorporated

Title of Class of Securities:  Common Stock

CUSIP Number:  457660108

          (Name, Address and Telephone Number of Person
       Authorized To Receive Notices and Communications)

     Mr. Peter J. Cobos c/o Kingdon Capital Management, LLC
 152 West 57th Street, New York, New York 10019, (212) 333-0100

     (Date of Event which Requires Filing of this Statement)

                       September 29, 1997

If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this schedule because of
Rule 13d-1(b)(3) or (4), check the following box [   ].

Note: Six copies of this statement, including all exhibits,
should be filed with the Commission.  See Rule 13d-1(a) for other
parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.

The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).



<PAGE>

CUSIP No. 9301907

1.  Name of Reporting Person
    S.S. or I.R.S. Identification No. of Above Person

         Kingdon Capital Management LLC

2.  Check the Appropriate Box if a Member of a Group

         a.
         b.   x

3.  SEC Use Only

4.  Source of Funds

         WC

5.  Check if Disclosure of Legal Proceedings is Required Pursuant
    to Items 2(d) or 2(e)

6.  Citizenship or Place of Organization

         Delaware

Number of Shares Beneficially Owned by Each Reporting Person
With:

7.  Sole Voting Power:

         749,000

8.  Shared Voting Power:


9.  Sole Dispositive Power:

         749,000

10. Shared Dispositive Power:


11. Aggregate Amount Beneficially Owned by Each Reporting Person

         749,000

12. Check Box if the Aggregate Amount in Row (11) Excludes
    Certain Shares





                                2



<PAGE>

13. Percent of Class Represented by Amount in Row (11)

         3.7%

14. Type of Reporting Person

         CO


The reason for the filing of this Amendment No. 2 to the
previously filed Schedule 13D is to show that the holdings of
Kingdon Capital Management LLC ("KCMC") in the shares of Common
Stock (the "Common Stock") of Insite Vision Incorporated ("ISV")
decreased below 5% due to the Company's issuance of more shares.
KCMC is currently deemed to be the beneficial owner of 3.7% of
the outstanding shares of Common Stock of ISV, which drops the
ownership percentage below 5%.

Item 1.  Security and Issuer

         No change

Item 2.  Identity and Background

         This statement is being filed o behalf of Kingdon
         Capital Management, LLC ("KCMC"), a Delaware limited
         liability company, M. Kingdon Offshore NV, a Netherlands
         Antilles corporation, (the "Offshore Fund"), and Kingdon
         Partners, L.P. and Kingdon Associates, L.P., each of
         which is a Delaware investment limited partnership (the
         "Partnerships," and, together with KCMC and the Offshore
         Fund, the "Reporting Persons").  KCMC's principal
         business is to act as an investment adviser and it acts
         as investment adviser or general partner to the Offshore
         Fund and the Partnerships.  The principal office of KCMC
         and the partnerships is at 152 West 57th Street, New
         York, New York 10019.  The principal office of the
         Offshore Fund is located at c/o Goldman Sachs (Cayman)
         Trust, Limited, P.O. Box 896, Harbour Centre, George
         Town, Grand Cayman, Cayman Islands.

         Mr. Mark Kingdon is the sole Managing Member of KCMC.
         None of Mr. Kingdon or the Reporting Persons have,
         during the last five years, been convicted in a criminal
         proceeding (excluding traffic violations or similar
         misdemeanors).  None of Mr, Kingdon or the Reporting
         Persons have, during the last five years, been a party
         to a civil proceeding of a judicial or administrative
         body of competent jurisdiction which resulted in a
         judgment, decree or final order enjoining future
         violations of, or prohibiting or mandating activities


                                3



<PAGE>

         subject to, federal or state securities laws or finding
         any violations with respect to such laws.

         Mr. Kingdon is a citizen of the United STates of
         America.

Item 3.  Source and Amount of Funds or Other Consideration.

         As of the date hereof, KCMC is deemed to beneficially
         own 749,000 shares of ISV Common Stock (including
         125,000 shares of Common Stock issuable upon exercise of
         warrants expiring on January 24, 2001 which may be
         exercised at a price of $3.25 per share (the
         "Warrants")).  All 749,000 shares of Common Stock
         (including 125,000 share issuable upon exercise of the
         Warrants) are held by entities and managed accounts over
         which KCMC has investment discretion.  The shares
         purchased since the original filing on Schedule 13D were
         purchased in an open-market transaction for a price of
         $1,000,000.  The funds for the purchase of the Common
         Stock and Warrants held in the entities and managed
         accounts over which KCMC has investment discretion have
         come from each entity's or account's own funds.  No
         leverage was used to purchase any Common Stock and
         Warrants.

Item 4.  Purpose of Transactions.

         This purpose of this amendment is to disclose our
         ownership percentage is less than 5%, as a result of
         share issuances by the Issuer.

Item 5.  Interest in Securities of Issuer.

         As of the date hereof, KCMC is deemed to be the
         beneficial owner of 749,000 shares of ISV Common Stock
         (including 125,000 shares issuable upon exercise of the
         Warrants).   Based on a 10-Q filed by ISV in September,
         1999, KCMC believes there to be 20,275,870 shares of ISV
         Common Stock outstanding.  Therefore, KCMC is deemed to
         beneficially own 3.7% of the outstanding shares of
         Common Stock.  KCMC has the sole power to vote, direct
         the vote, dispose of or direct the disposition of all
         the shares of Common Stock that it is currently deemed
         to beneficially own.

Item 6.  Contracts, Arrangements, Understandings or
         Relationships with Respect to Securities of the Issuer

         No change.



                                4



<PAGE>

Item 7.  Material to be Filed as Exhibits.

         N/A
    Signature





         The undersigned, after reasonable inquiry and to the
         best of its knowledge and belief, certifies that the
         information set forth in this statement is true,
         complete and correct.

Date:  January 11, 2000



Kingdon Capital Management, LLC


By: /s/ Peter J. Cobos

    __________________________
    Chief Financial Officer




























                                5
48400.002AP4



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission